Apollo medical holdings, inc. (AMEH)
CashFlow / Quarterly
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Jan'14Dec'13Oct'13Sep'13Jul'13Jun'13Apr'13Mar'13Jan'13Oct'12Jul'12Apr'12Jan'12Oct'11Jul'11Apr'11
Cash flows from operating activities
Net income

-1,279

10,738

10,663

-2,450

-1,941

38,625

7,865

15,717

42,166

-4,233

-3,833

11,723

-1,484

-1,470

-899

-4,116

-1,532

-293

-2,230

15

-1,391

1,535

-1,507

-710

-

-964

-

-980

-

-1,932

-849

-145

-822

-4,721

-3,202

-157

-426

58

-122

-228

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization

4,960

4,920

4,454

4,417

4,483

4,843

4,918

5,058

13,927

155

155

4,836

148

170

164

64

145

77

63

-64

194

193

11

5

-

6

-

6

-

6

6

4

6

5

4

4

2

3

2

3

Loss on disposal of property and equipment

0

0

0

0

-0

0

0

-41

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Provision for doubtful accounts

-

-

-

951

-

-

-

247

-315

83

6

224

91

-97

167

239

196

0

0

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Share-based compensation

540

330

330

345

202

202

202

833

2,003

195

223

321

350

246

247

924

26

68

83

126

156

856

119

60

-

-22

-

568

-

1,552

-

45

-

-

-

-

-

-

-

-

Unrealized (gain) loss from investment in equity securities

2

-8

6

7

-14

5

-7

-8

6

79

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on debt extinguishment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

23

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Issuance of shares for services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

87

-

244

-

393

-

-

1,119

59

42

89

0

0

63

Non-cash stock option expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

270

-

800

-

229

-

-

427

21

61

7

7

7

7

Amortization of deferred financing costs

-

-

-

-

-

-

-

-

-

53

53

6

0

0

37

17

31

16

29

29

29

33

28

25

-

165

-

-7

-

11

30

9

27

20

19

21

9

9

9

9

Amortization adjustment to debt discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12

5

-163

115

111

110

98

79

19

-

-39

-

71

-

44

32

15

180

163

163

163

0

0

0

0

Change in fair value of derivative instrument

-

-

-

-

-

-

-

-

-1,567

0

0

1,522

300

511

822

-722

430

96

-213

352

358

152

-30

0

-

0

-

0

-

0

-

-

-

-

-

-

-

-

-

-

Income (Loss) from Equity Method Investments

-8,062

2,053

-42

-849

-5,552

-4,215

1,669

-28

-1,083

-1,461

-795

2,227

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax

-6,615

363

2,073

-2,623

-15,480

6,428

-2,100

2,807

-14,945

-1,311

-6,529

2,109

-

-

-

-136

3

3

3

-64

-46

59

0

4

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on sale of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on change in fair value of warrant and derivative liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

-

0

-

0

3,063

2,914

-123

-

-

-

-

Changes in operating assets and liabilities, net of acquisition amounts:
Restricted cash

-

-

-

-

-

-

-

-

-

0

-19

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Receivable, net

-8,808

-1,317

-100

-486

4,747

-73

-3,113

-1,296

10,860

-483

-76

-14,410

1,498

480

774

-21

-165

322

-108

61

-142

997

-4

-1

-

-90

-

22

-

-346

-262

158

296

248

-148

152

-592

181

16

-12

Receivable, net – related parties

7,299

-18,529

5,154

7,511

-14,997

36,126

-15,396

22,631

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other receivable

1,360

1,822

652

11,244

0

0

0

0

-62

-433

342

154

22

-24

-265

-187

-177

-39

120

175

-5,370

5,382

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Due to officers

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

-

0

-

-18

0

0

6

-

-

-

-

Due from affiliates

-

-

-

-

-

-

-

-

-

0

-18

0

-1

0

-0

0

0

-31

14

24

-37

-62

20

22

-

-0

-

0

-

-17

-5

12

-11

2

0

2

-

-

-

0

Prepaid expenses and other current assets

-157

173

2,011

728

2,732

-2,692

3,005

-232

-1,718

15

13

428

68

-78

215

21

-59

151

-20

120

-16

8

5

-11

-

6

-

-15

-

-0

12

-12

-12

21

5

8

-35

28

-3

-11

Right-of-use assets

602

779

650

447

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid commission and financing cost

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Deferred financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

560

-3

-0

-513

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

47

281

-199

442

-29

-68

35

59

172

-2

-3

54

0

8

-2

-4

7

0

-6

3

102

3

-2

2

-

-10

-

4

-

0

0

0

-8

0

0

1

-

-

-

0

Accounts payable and accrued expenses

-9,751

1,528

-19,238

22,578

-54,370

32,393

477

-1,169

-494

-9,170

8,329

-2,350

3,274

289

-317

653

-1,220

801

790

244

-1,563

2,175

-4

621

-

90

-

-116

-

109

-86

50

322

482

-56

15

48

-162

177

6

Incentives payable

-

0

0

0

-

-104

-9,795

-6,600

-

82

1,700

-9,721

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fiduciary accounts payable

292

-64

-286

546

0

722

-91

-630

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent liability

-

-

-

-

-

-

-

-

-

-31

-31

-31

-5

56

33

48

9

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Medical liabilities

3,834

-2,407

6,557

-10,375

34,601

-33,347

-2,257

5,138

-23,006

10,976

17,949

-257

-288

-442

-158

731

601

189

-112

-582

163

505

163

0

-

-114

-

4

-

-4

-

-

-

-

-

-

-

-

-

-

Income taxes payable

3,136

1,392

-12,831

1,209

10,336

-1,614

-4,714

4,416

-12,345

8,871

-406

4,267

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase in cash on consolidation of variable interest entity

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by operating activities

3,588

32,102

-18,051

-3,966

-6,368

18,449

8,680

4,735

9,180

17,952

3,595

21,105

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-630

-

-119

-

12

-178

-202

325

66

-131

-83

-249

62

-115

Net cash provided by (used in) operating activities

-

-

-

-

-

-

-

-

-

-

22,615

-

-

-

-2,266

-

-1,499

199

-528

-924

2,774

-1,023

-1,098

-8

-

-541

-

-473

-

160

-

-

-

-

-

-

-

-

-

-

Cash flows from investing activities
Purchases of marketable securities

115,381

12

0

8

0

5

0

3

0

3

0

1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Advances on loans receivable

-

-

-

-

-

-

-

-

5,000

0

0

5,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from Equity Method Investment, Distribution, Return of Capital

-

-

-

-

-

-

-

-

240

0

0

1,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease liabilities

-

-

-

-416

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments to Acquire Businesses, Net of Cash Acquired

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

279

1,128

2,163

-216

0

-

-19

-

248

-

0

-

-

-

-

-

-

-

-

-

-

Proceeds on sale of investments - cost method

-

-

-

-

-

-

-

-

-

0

0

25

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of property and equipment

235

430

272

103

302

185

197

485

1,709

20

36

318

53

42

163

96

123

42

0

7

21

3

11

12

-

8

-

-5

-

7

3

3

32

2

1

9

-

-

-

-

Net cash (used in) provided by investing activities

-120,266

-10,118

-50,133

-111

-4,934

17

-19,776

-489

31,067

368

-424

-4,295

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-102

-

-8

-

-3

-3

-32

11

-1

-9

-

-

-

-

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-36

-

-

-

-163

-

-123

-42

0

-525

-711

-2,167

204

-12

-

10

-

-243

-

-7

-

-

-

-

-

-

-

-

-

-

Cash flows from financing activities
Repayment of bank loan and lines of credit

-

44,600

8,000

40

-

118

116

140

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Dividends paid

1,047

49,728

941

10,000

1,033

4,725

10,000

2,000

957

0

740

8,750

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from notes and line of credit payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Principal payments on lines of credit

-

-

-

-

-

-

-

-

-

0

37

50

37

50

12

6

1,000

0

0

-

-

-

-

2,811

-500

-

405

-

-

94

-

0

-

-

-

-

-

-

-

-

Change in noncontrolling interest capital

-

-

-

-

-

-

-

-

0

0

27

-27

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Borrowings on line of credit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

-

-

-

0

270

-

-

-

-

Principal payments on notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

122

87

551

175

0

-

515

-

-55

-

0

-

-

-

-

-

-

-

-

-

-

Payment of capital lease obligations

25

25

25

25

24

24

24

24

24

23

23

30

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of medical clinic acquisition notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

256

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Repayments on convertible notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

98

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from the exercise of stock options and warrants

-

-

-

-

-

-

-

-

-

0

0

425

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options and warrants

723

1,502

758

139

422

1,226

423

1,923

-

85

0

-

0

39

132

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase in restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of convertible note payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-298

-

-430

-300

0

0

0

0

0

-

-

-

-

Proceeds from issuance of convertible notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

120

-

100

100

880

0

0

0

-

-

-

-

Cash payments in connection with convertible note redemption

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Debt issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

232

-

303

-

-24

24

-

11

0

49

55

0

0

-

-

-

-

Proceeds from common stock offering

0

549

50

155

0

0

200

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Distributions to non-controlling interest shareholder

-

-

-

-

-

-

-

-

-

0

0

0

150

600

450

107

0

0

595

0

0

600

0

200

-

0

-

120

-

120

0

0

30

270

0

100

-

-

-

-

Repurchase of common shares

7,529

0

0

40

5,047

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in financing activities

-

-

-

-

-

-

-

-

-

-

-37

-

-

-

-330

-

2,343

-122

-595

-487

938

1,378

-175

5,401

-

963

-

328

-

215

-

-

-

-

-

-

-

-

-

-

Net cash used in financing activities

-10,376

152,076

31,441

-9,810

-5,802

-3,642

-1,490

-241

-6,640

784

-736

-8,383

-

-

-

-

-

-

-

-

-

-

-

-

-

-

492

-

285

-

389

100

911

-95

0

170

-

-

-

-

Net (decrease) increase in cash, cash equivalents and restricted cash

-

-

-

-13,888

-

-

-

4,005

-

10,506

2,434

8,427

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental disclosures of cash flow information
Interest paid

-

-

-

-

-

-

-

-

-

-

0

-

-

-

7

-

118

279

100

254

158

205

150

84

-

348

-

64

-

105

18

18

145

0

0

15

65

1

62

0

Cash paid for income taxes

2,300

1,200

16,700

0

5,610

6,420

11,612

0

22,833

0

17

1,511

-2

0

16

82

61

0

32

13

0

7

11

3

-

5

-

31

-

6

9

9

0

0

0

8

-

-

0

1

Cash paid for interest

3,257

560

257

181

175

142

70

73

49

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental disclosures of non-cash investing and financing activities
Cashless exercise of stock options

0

0

0

0

0

0

0

-0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

APC stock issued in exchange for AMG

-

-

-

-

-

-

-

-

-

0

0

425

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

70

0

210

Deferred tax liability adjusted to goodwill

-5,205

3,184

8,355

0

0

0

196

914

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cumulative effect adjustment for ASC 606 included in accounts receivable

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cumulative effect adjustment for ASC 606 included in deferred tax liabilities

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Holdback liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

239

0

136

-

-

0

-

0

-

0

-

-

-

-

-

-

-

-

-

-

Convertible note warrant

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible note conversion feature

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition related warrant consideration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition related consideration fair value of units issued by consolidated subsidiary

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition related deferred tax liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Pre-acquisition net equity of noncontrolling interest in variable interest entity

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Reclassification of fiduciary cash to payable

-

-

-

-

-

-

-

-

-

48

-29

32

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Reconciliation of cash, cash equivalents, and restricted cash
Net change in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-1,002

22,542

4,675

195

-2,716

-2,760

4,625

719

34

-1,123

-1,937

3,001

-1,812

-1,069

5,380

-

432

-

-388

-

368

398

-81

675

241

65

29

-85

-93

61

-115

NNA term loan discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,254

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Shares issued in connection with convertible notes redemption

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

51

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Fair value of warrant liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,354

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

NNA shares issuance discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,100

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Warrants issued in connection with convertible note issuance

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13

-

30

-

6

6

186

200

0

0

-

-

-

-

Contingent consideration payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

367

Shares issuable and issued for deferred financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-56

-

0

-

56

-

45

45

54

118

0

25

-

-

-

-

Notes payable issued in connection with medical clinic acquisitions

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Settlement of stock issuable liability with issuance of shares

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fair value of embedded conversion feature reacquired in connection with convertible notes redemption

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Shares issued for prepaid director services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

-

-

-

0

47

-

-

-

-